Advertisement
Opthea Limited

Opthea Limited Fundamental Analysis

OPTNASDAQ
HealthcareBiotechnology
$3.41
$0.05(1.49%)
U.S. Market opens in 16h 8m
Advertisement

Opthea Limited Fundamental Analysis

Opthea Limited (OPT) shows weak financial fundamentals with a PE ratio of -3.28, profit margin of -6551.80%, and ROE of 1.18%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.06

Areas of Concern

ROE1.18%
Operating Margin-6263.52%
Current Ratio0.22
We analyze OPT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -614166.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-614166.4/100

We analyze OPT's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPT struggles to generate sufficient returns from assets.

ROA > 10%
-2.87%

Valuation Score

Excellent

OPT trades at attractive valuation levels.

PE < 25
-3.28
PEG Ratio < 2
-0.06

Growth Score

Weak

OPT faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

OPT shows balanced financial health with some risks.

Debt/Equity < 1
-1.23
Current Ratio > 1
0.22

Profitability Score

Weak

OPT struggles to sustain strong margins.

ROE > 15%
118.01%
Net Margin ≥ 15%
-6551.80%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPT Expensive or Cheap?

P/E Ratio

OPT trades at -3.28 times earnings. This suggests potential undervaluation.

-3.28

PEG Ratio

When adjusting for growth, OPT's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Opthea Limited at -2.59 times its book value. This may indicate undervaluation.

-2.59

EV/EBITDA

Enterprise value stands at -32.59 times EBITDA. This is generally considered low.

-32.59

How Well Does OPT Make Money?

Net Profit Margin

For every $100 in sales, Opthea Limited keeps $-6551.80 as profit after all expenses.

-6551.80%

Operating Margin

Core operations generate -6263.52 in profit for every $100 in revenue, before interest and taxes.

-6263.52%

ROE

Management delivers $1.18 in profit for every $100 of shareholder equity.

1.18%

ROA

Opthea Limited generates $-2.87 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.87%

Following the Money - Real Cash Generation

Operating Cash Flow

Opthea Limited generates limited operating cash flow of $-1.29B, signaling weaker underlying cash strength.

$-1.29B

Free Cash Flow

Opthea Limited generates weak or negative free cash flow of $-1.29B, restricting financial flexibility.

$-1.29B

FCF Per Share

Each share generates $-1.04 in free cash annually.

$-1.04

FCF Yield

OPT converts -3.76% of its market value into free cash.

-3.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.59

vs 25 benchmark

P/S Ratio

Price to sales ratio

169426.29

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.22

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.18

vs 25 benchmark

ROA

Return on assets percentage

-2.87

vs 25 benchmark

ROCE

Return on capital employed

0.77

vs 25 benchmark

How OPT Stacks Against Its Sector Peers

MetricOPT ValueSector AveragePerformance
P/E Ratio-3.2829.30 Better (Cheaper)
ROE118.01%418.00% Weak
Net Margin-655180.00%-11410.00% (disorted) Weak
Debt/Equity-1.230.77 Strong (Low Leverage)
Current Ratio0.225.08 Weak Liquidity
ROA-286.87%-177.00% (disorted) Weak

OPT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Opthea Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ